Yiming Hu

Yiming Hu

Auto-generated profile, based on publicly available information

Yiming Hu

Yale University

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 February 2019 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
YHYiming Hu
Yiming Hu
MLMo Li
Mo Li
QLQiongshi Lu
Qiongshi Lu
HWHaoyi Weng
Haoyi Weng
JWJiawei Wang
Jiawei Wang
HZHongyu Zhao
Hongyu Zhao

8 June 2017 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
YHYiming Hu
Yiming Hu
QLQiongshi Lu
Qiongshi Lu
RPRyan Powles
Ryan Powles
XYXinwei Yao
Xinwei Yao
CYCan Yang
Can Yang
HZHongyu Zhao
Hongyu Zhao
Genetic risk prediction is an important goal in human genetics research and precision medicine. Accurate prediction models will have great impacts on both disease prevention and early treatment strategies. Despite the identification of thousands of disease-associated genetic variants through genome wide association studies (GWAS), genetic risk prediction accuracy remains moderate for most diseases, which is largely due to the challenges in both identifying all the functionally relevant variants and accurately estimating their effect sizes in the presence of linkage disequilibrium. In this paper, we introduce AnnoPred, a principled framework that leverages diverse types of genomic and epigenomic functional annotations in genetic risk prediction for complex diseases. AnnoPred is trained using GWAS summary statistics in a Bayesian framework in which we explicitly model various functional annotations and allow for linkage disequilibrium estimated from reference genotype data. Compared with state-of-the-art risk prediction methods, AnnoPred achieves consistently improved prediction accuracy in both extensive simulations and real data. Genetic risk prediction plays a significant role in precision medicine. Accurate prediction models could have great impact on disease prevention and early treatment strategies. For example, mutations in BRCA1 and BRCA2 have been used to evaluate women’s breast cancer risk and as a guideline for early screening. However, genetic risk prediction models also present important challenges, including extreme high-dimensionality, limited access to and efficient computational methods for individual-level genotype data. To make use of rich GWAS summary statistics, we propose a novel method to address these challenges by integrating genomic functional annotations, which have been successfully applied in GWAS to generate biological insights. We demonstrate the improvement in accuracy in both extensive simulation studies and real data analysis of breast cancer, Crohn’s disease, celiac disease, rheumatoid arthritis and type-II diabetes.

9 June 2017 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
YHYiming Hu
Yiming Hu
QLQiongshi Lu
Qiongshi Lu
WLWei Liu
Wei Liu
YZYuhua Zhang
Yuhua Zhang
MLMo Li
Mo Li
HZHongyu Zhao
Hongyu Zhao
Accurate prediction of disease risk based on genetic factors is an important goal in human genetics research and precision medicine. Advanced prediction models will lead to more effective disease prevention and treatment strategies. Despite the identification of thousands of disease-associated genetic variants through genome-wide association studies (GWAS) in the past decade, accuracy of genetic risk prediction remains moderate for most diseases, which is largely due to the challenges in both identifying all the functionally relevant variants and accurately estimating their effect sizes. In this work, we introduce PleioPred, a principled framework that leverages pleiotropy and functional annotations in genetic risk prediction for complex diseases. PleioPred uses GWAS summary statistics as its input, and jointly models multiple genetically correlated diseases and a variety of external information including linkage disequilibrium and diverse functional annotations to increase the accuracy of risk prediction. Through comprehensive simulations and real data analyses on Crohn’s disease, celiac disease and type-II diabetes, we demonstrate that our approach can substantially increase the accuracy of polygenic risk prediction and risk population stratification, i.e. PleioPred can significantly better separate type-II diabetes patients with early and late onset ages, illustrating its potential clinical application. Furthermore, we show that the increment in prediction accuracy is significantly correlated with the genetic correlation between the predicted and jointly modeled diseases. Genetic risk prediction plays a significant role in precision medicine. Accurate prediction models could have great impact on disease prevention and treatment strategies. However, prediction accuracies for most complex diseases remain moderate mainly due to the challenges in identifying and quantifying the effects of genetic variants from millions of markers, limited access to individual-level genotype data, and lack of efficient computational methods. Up to now, most methods have been focused on predicting disease risk using data from a single trait. With the discovery of genetic correlations among many complex diseases, incorporating data of genetically correlated diseases could have the potential to increase prediction accuracy. Current statistical methods are not able to fully exploit the richness of these kinds of data to take into account the shared genetic architecture. To make use of commonly available GWAS summary statistics, we propose a novel method to address these challenges by jointly modeling genetically correlated diseases and integrating genomic functional annotations. We demonstrate the substantial improvement in accuracy in both extensive simulation studies and real data analysis of Crohn’s disease, celiac disease and type-II diabetes. Furthermore, we show that the increment in prediction accuracy is significantly correlated with the genetic correlation between the predicted and jointly modeled diseases.

1 January 1998 in IEEE Micro
Verified
Journal Article
Closed access
YHYiming Hu
Yiming Hu
QYQing Yang
Qing Yang
Large RAM caches are generally used to speed up disk accesses. Such caches more effectively improve read performance than write performance, since write requests must be frequently written into disks to protect them from data loss or damage due to system failures. While Non-volatile RAM (NVRAM) caches can be used to improve write performance, large NVRAM caches are too expensive for many applications. This paper presents a new disk cache architecture called DCD, Disk Caching Disks. DCD takes the advantage of large data transfer sizes and uses inexpensive disk space to provide a high-performance, low-cost and reliable caching solution.

21 March 2018 in bioRxiv
Verified
Preprint
Open access
PDF file
YHYiming Hu
Yiming Hu
MLMo Li
Mo Li
QLQiongshi Lu
Qiongshi Lu
HWHaoyi Weng
Haoyi Weng
JWJiawei Wang
Jiawei Wang
HZHongyu Zhao
Hongyu Zhao
Transcriptome-wide association analysis is a powerful approach to studying the genetic architecture of complex traits. A key component of this approach is to build a model to predict (impute) gene expression levels from genotypes from samples with matched genotypes and expression levels in a specific tissue. However, it is challenging to develop robust and accurate imputation models with limited sample sizes for any single tissue. Here, we first introduce a multi-task learning approach to jointly impute gene expression in 44 human tissues. Compared with single-tissue methods, our approach achieved an average 39% improvement in imputation accuracy and generated effective imputation models for an average 120% (range 13%-339%) more genes in each tissue. We then describe a summary statistic-based testing framework that combines multiple single-tissue associations into a single powerful metric to quantify overall gene-trait association at the organism level. When our method, called UTMOST, was applied to analyze genome wide association results for 50 complex traits (N total =4.5 million), we were able to identify considerably more genes in tissues enriched for trait heritability, and cross-tissue analysis significantly outperformed single-tissue strategies (p=1.7e-8). Finally, we performed a cross-tissue genome-wide association study for late-onset Alzheimer’s disease (LOAD) and replicated our findings in two independent datasets (N total =175,776). In total, we identified 69 significant genes, many of which are novel, leading to novel insights on LOAD etiologies.

8 March 2016 in Biometrics
Verified
Journal Article
Closed access
PDF file
YHYiming Hu
Yiming Hu
HZHongyu Zhao
Hongyu Zhao